Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nalbuphine-induced pulmonary edema.

A Stadnyk, R F Grossman

    Chest
    |November 1, 1986
    PubMed
    Summary

    Nalbuphine, a synthetic narcotic analgesic, can cause acute pulmonary edema. This adverse effect may be common to all opiate drugs, necessitating careful patient monitoring during therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Etiological diagnosis of pneumonia: A goal worth pursuing?

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    Concentrations of krypton-85 near the Nevada Test Site.

    Environmental science & technology·2012
    Same author

    Out-patient management of patients with chronic obstructive lung disease.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Management of chronic bronchitis and acute exacerbations of chronic bronchitis.

    International journal of antimicrobial agents·2008
    Same author

    Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2007
    Same author

    Use of guidelines and risk stratification in acute exacerbations of chronic obstructive pulmonary disease.

    Seminars in respiratory and critical care medicine·2005

    Area of Science:

    • Pharmacology
    • Toxicology
    • Pulmonology

    Background:

    • Nalbuphine is a synthetic kappa-opioid receptor agonist and mu-opioid receptor antagonist used for pain management.
    • Acute pulmonary edema is a life-threatening condition characterized by fluid accumulation in the lungs.

    Observation:

    • A patient receiving nalbuphine therapy developed acute pulmonary edema.
    • Other potential causes for the pulmonary edema were ruled out, isolating nalbuphine as the likely culprit.

    Findings:

    • Nalbuphine, a synthetic narcotic analgesic, was associated with the development of acute pulmonary edema.
    • This case suggests that nalbuphine shares the potential to induce acute pulmonary edema with other opiate drugs.

    Implications:

    • Clinicians should be aware of the potential for nalbuphine to cause acute pulmonary edema.
    • This finding may indicate a class effect among opiate analgesics regarding pulmonary edema risk.
    • Further research is warranted to explore the mechanisms and prevalence of opiate-induced pulmonary edema.

    Related Experiment Videos